Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

Abstract

Long-term treatment of CHD patients with atorvastatin to achieve NCEP lipid targets significantly reduces total and coronary mortality, coronary morbidity and stroke, in comparison to patients receiving 'usual' medical care. Treatment with atorvastatin is well tolerated and cost-effective.

Keywords

MedicineAtorvastatinMyocardial infarctionNational Cholesterol Education ProgramInternal medicineStatinUnstable anginaHeart failureCholesterolCardiologyAspirinAngina

Affiliated Institutions

Related Publications

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

Christopher P. Cannon , Eugene Braunwald , Carolyn H. McCabe +7 more

Among patients who have recently had an acute coronary syndrome, an intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular eve...

2004 New England Journal of Medicine 4868 citations

Prediction of Coronary Heart Disease Using Risk Factor Categories

Peter W.F. Wilson , Ralph B. D’Agostino , Daniel Levy +3 more

Background —The objective of this study was to examine the association of Joint National Committee (JNC-V) blood pressure and National Cholesterol Education Program (NCEP) chole...

1998 Circulation 9466 citations

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

Steven E. Nissen , E. Murat Tuzcu , Paul Schoenhagen +10 more

For patients with coronary heart disease, intensive lipid-lowering treatment with atorvastatin reduced progression of coronary atherosclerosis compared with pravastatin. Compare...

2004 JAMA 2332 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

A. Tonkin , Philip E Alyward , David Colquhoun +96 more

Pravastatin therapy reduced mortality from coronary heart disease and overall mortality, as compared with the rates in the placebo group, as well as the incidence of all prespec...

1998 New England Journal of Medicine 5274 citations

Publication Info

Year: 2002
Type: article
Volume: 18
Issue: 4
Pages: 220-228
Citations: 529
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

529

OpenAlex

Cite This

APA Style

                            
                                
                                    Vasilios G. Athyros, 
                                
                                    Athanasios A. Papageorgiou, 
                                
                                    Bodosakis R. Mercouris
                                
                                et al.
                            
                            (2002). 
                            Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention. 
                            Current Medical Research and Opinion
                            , 18
                            (4)
                            , 220-228.
                            https://doi.org/10.1185/030079902125000787
                        

Identifiers

DOI: 10.1185/030079902125000787